Tokyo, July 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062195) titled 'Study on the Clinical Significance of Comorbid Pulmonary Nontuberculous Mycobacterial Disease in Patients with COPD' on July 10.
Study Type:
Observational
Primary Sponsor:
Institute - Kurume University
Condition:
Condition - COPD
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To determine whether the coexistence of pulmonary nontuberculous mycobacterial disease adversely affects the symptoms, quality of life, or clinical findings of patients with COPD.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - 40
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - COPD
Key exclusion criteria - none
Target Size - 600
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 10 Day
Anticipated trial start date - 2026 Year 07 Month 30 Day
Last follow-up date - 2027 Year 06 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071174
Disclaimer: Curated by HT Syndication.
